More importantly, survival analysis demonstrated that the TERTp+/TP53+ group had significantly shorter DFS and the TERTp‐/TP53+ group had significantly longer DFS in NCC HCC cohort (Figure 3C, p = 0.028). Here, TP53 is linked to hepatocellular carcinoma.